A Review on Docking Studies of Indole Moiety as Potent Inhibitor of Tubulin Polymerization (original) (raw)
Synthesis, biological evaluation and molecular docking studies of trans-indole-3-acrylamide derivatives, a new class of tubulin polymerization inhibitors
Sultan Nacak Baytas
Bioorganic & medicinal chemistry
View PDFchevron_right
Indole, a core nucleus for potent inhibitors of tubulin polymerization
Romano Silvestri
Medicinal Research Reviews, 2007
View PDFchevron_right
Cytotoxic substituted indolizines as new colchicine site tubulin polymerisation inhibitors
Monica Sardaru
Journal of Enzyme Inhibition and Medicinal Chemistry
View PDFchevron_right
New 6- and 7-heterocyclyl-1H-indole derivatives as potent tubulin assembly and cancer cell growth inhibitors
Patrizia Lavia
European journal of medicinal chemistry, 2018
View PDFchevron_right
An orally bioavailable, indole-3-glyoxylamide based series of tubulin polymerization inhibitors showing tumor growth inhibition in a mouse xenograft model of head and neck cancer
Melanie Wong
Journal of Medicinal Chemistry, 2015
View PDFchevron_right
Anti-tubulin agents of natural origin: Targeting taxol, vinca, and colchicine binding domains
Syed Shafi
European Journal of Medicinal Chemistry, 2019
View PDFchevron_right
Design, Synthesis, and Biological Evaluation of Stable Colchicine Binding Site Tubulin Inhibitors as Potential Anticancer Agents
James Dalton
Journal of Medicinal Chemistry
View PDFchevron_right
IRC-083927 is a new tubulin binder that inhibits growth of human tumor cells resistant to standard tubulin-binding agents
Grégoire Prevost
Molecular Cancer Therapeutics, 2008
View PDFchevron_right
Discovery of Novel 2-Aryl-4-benzoyl-imidazoles Targeting the Colchicines Binding Site in Tubulin As Potential Anticancer Agents
James Dalton
Journal of Medicinal Chemistry, 2010
View PDFchevron_right
Synthesis of C 5 -tethered indolyl-3-glyoxylamide derivatives as tubulin polymerization inhibitors
Suresh Bhargava
European Journal of Medicinal Chemistry, 2017
View PDFchevron_right
Design, Synthesis and Biological Evaluation of Imidazole-Substituted/Fused Aryl Derivatives Targeting Tubulin Polymerization as Anticancer Agents
Dr Satyendra Rajput
SynOpen, 2023
View PDFchevron_right
Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents
Subhas Samanta
European Journal of Medicinal Chemistry, 2015
View PDFchevron_right
Arylthioindole Inhibitors of Tubulin Polymerization. 3. Biological Evaluation, Structure−Activity Relationships and Molecular Modeling Studies
Romano Silvestri
Journal of Medicinal Chemistry, 2007
View PDFchevron_right
Toward Highly Potent Cancer Agents by Modulating the C-2 Group of the Arylthioindole Class of Tubulin Polymerization Inhibitors
Erica Di Cesare, Eleonora Da Pozzo, Patrizia Lavia
Journal of Medicinal Chemistry, 2013
View PDFchevron_right
Molecular Cancer apeutics apeutic Discovery 7 , a Novel Antimitotic Indole , Displays a Potent In vitro and Ther ivo Antitumor Activity with Less Neurotoxicity
James Dalton
2010
View PDFchevron_right
Interaction of a new bis-indol derivative, KAR-2 with tubulin and its antimitotic activity
Judit Ovádi, Zoltán Urbányi, Ferenc Orosz
British Journal of Pharmacology, 1997
View PDFchevron_right
Imidazoquinoxaline anticancer derivatives and imiquimod interact with tubulin: Characterization of molecular microtubule inhibiting mechanisms in correlation with cytotoxicity
Martine Pugnière
PLOS ONE, 2017
View PDFchevron_right
Discovery of 4-Aryl-2-benzoyl-imidazoles as Tubulin Polymerization Inhibitor with Potent Antiproliferative Properties
James Dalton
Journal of Medicinal Chemistry, 2013
View PDFchevron_right
Indomethacin derivatives as tubulin stabilizers to inhibit cancer cell proliferation
Snigdha Chennamaneni
Bioorganic & medicinal chemistry, 2016
View PDFchevron_right
Design and Synthesis of 2-Heterocyclyl-3-arylthio-1 H-indoles as Potent Tubulin Polymerization and Cell Growth Inhibitors with Improved Metabolic Stability
Antonio Lavecchia
2011
View PDFchevron_right
{"__content__"=>"New (3-(1-benzo[]imidazol-2-yl))/(3-(3-imidazo[4,5-]pyridin-2-yl))-(1-indol-5-yl)(3,4,5-trimethoxyphenyl)methanone conjugates as tubulin polymerization inhibitors.", "i"=>[{"__content__"=>"H"}, {"__content__"=>"d"}, {"__content__"=>"H"}, {"__content__"=>"b"}, {"__content__"=>"H"}]}
lakshma nayak
MedChemComm, 2018
View PDFchevron_right
3-Substituted 2-Phenylimidazo[2,1-b]benzothiazoles: Synthesis, Anticancer Activity, and Inhibition of Tubulin Polymerization
PRANJAL SHARMA
ChemMedChem, 2012
View PDFchevron_right
Inhibition of Tubulin Polymerization by 5,6-Dihydroindolo[2,1-a]isoquinoline Derivatives
Michael Goldbrunner
Journal of Medicinal Chemistry, 1997
View PDFchevron_right
New Multi-Targeted Antiproliferative Agents: Design and Synthesis of IC261-Based Oxindoles as Potential Tubulin, CK1 and EGFR Inhibitors
Mohamed Badr
Pharmaceuticals, 2021
View PDFchevron_right
Design and Synthesis of Pyrazole - Oxindole Conjugates Targeting Tubulin Polymerization as New Anticancer Agents
Anver Basha Shaik
View PDFchevron_right
Inhibition of Microtubule Dynamics in Cancer Cells by Indole-Modified Latonduine Derivatives and Their Metal Complexes
Junior Gonzales
Inorganic Chemistry, 2022
View PDFchevron_right